Literature DB >> 29028255

Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.

Manuel Colombo1, Matthew Jeronimo1, George Astrakianakis1, Chirag Apte1, Chun-Yip Hon2.   

Abstract

This paper describes a novel wipe sampling and high-performance liquid chromatography/tandem mass spectrometry (HPLC-MS/MS) method capable of simultaneously detecting 10 antineoplastic drugs (5-fluorouracil, oxaliplatin, methotrexate, vindesine, ifosfamide, cyclophosphamide, vincristine, vinblastine, docetaxel, and paclitaxel). The good overall recoveries and sensitivity values of this method along with the comparatively short run time (8 min) allows for its use in routine monitoring in health care facilities. The long-term behavior of the studied drugs on contaminated surfaces and the effect of surface roughness on drug recoveries were studied to gain insights about how these environmental variables influence the detection, cleaning, and occupational exposure of these drugs. Surfaces with higher roughness parameter (Ra) values (rougher) had the lowest recoveries while those with lower Ra (smoother) presented the highest recoveries. Long-term assessments evidence distinctive drug behaviors with oxaliplatin, vindesine, vincristine, and vinblastine being the less persistent drugs (~20% was recovered after 24 h) and docetaxel and paclitaxel the most persistent drugs with recoveries of 40% and 80% after 1 month. This information indicates the importance of collecting ancillary information about drug usage (throughput, timing, cleaning procedures, etc.) to interpret the results in the context of potential exposure. Finally, the method was successfully applied to evaluate trace surface contamination down to the single picogram per square centimeter in multiple work areas within three local health care centers on Vancouver Island, Canada.
© The Author 2017. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Entities:  

Keywords:  LC-MS/MS; antineoplastic drugs; environmental monitoring; occupational exposure; stability; surface wipe

Mesh:

Substances:

Year:  2017        PMID: 29028255     DOI: 10.1093/annweh/wxx070

Source DB:  PubMed          Journal:  Ann Work Expo Health        ISSN: 2398-7308            Impact factor:   2.179


  6 in total

1.  Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy.

Authors:  Nicolas Guichard; Julien Boccard; Serge Rudaz; Pascal Bonnabry; Sandrine Fleury Souverain
Journal:  Eur J Hosp Pharm       Date:  2019-07-17

2.  A snapshot of drug background levels on surfaces in a forensic laboratory.

Authors:  Edward Sisco; Marcela Najarro; Amber Burns
Journal:  Forensic Chem       Date:  2018

3.  Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus.

Authors:  Elpidoforos S Soteriades; Sofia C Economidou; Artemis Tsivitanidou; Petros Polyviou; Amanda Lorimer; Nikos Katodritis; Stavroula Theophanous-Kitiri
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

4.  Occupational Exposure Assessment to Antineoplastic Drugs in Nine Italian Hospital Centers over a 5-Year Survey Program.

Authors:  Cristina Sottani; Elena Grignani; Marco Cornacchia; Sara Negri; Francesco Saverio Robustelli Della Cuna; Danilo Cottica; Dario Bruzzese; Paolo Severi; Daniele Strocchi; Giovanni Verna; Veruscka Leso; Ivo Iavicoli
Journal:  Int J Environ Res Public Health       Date:  2022-07-14       Impact factor: 4.614

Review 5.  Cytostatics in Indoor Environment: An Update of Analytical Methods.

Authors:  M Francisca Portilha-Cunha; A Alves; Mónica S F Santos
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-15

6.  Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.

Authors:  Antoine Villa; Mathieu Molimard; Emmanuelle Bignon; Béatrice Martinez; Magali Rouyer; Simone Mathoulin-Pelissier; Isabelle Baldi; Catherine Verdun-Esquer; Mireille Canal-Raffin
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.